These are this Tuesday’s top four day trader and active trader alert stories. We have more details and analysis via links to each story at VSInvestor.com: Celgene Corporation (NASDAQ: CELG) is trading…
These are this morning’s top day trader and active trader alert stocks, with more details and analysis over at VSInvestor.com with a link to each story: Geron Corporation (NASDAQ: GERN), StemCells Inc.…
Tickerspy’s Stem Cell Stock Index (*RSXTM) took off today, rising nearly 13%.  The movement followed a release from the National Institutes of Health (NIH) announcing that 13 embryonic stem cell lines were…
Douglas A. McIntyre These are ten of the top analyst upgrades, downgrades, and initiations seen early this Monday morning from Wall Street research notes: Accenture (NYSE: ACN) Cut to Neutral at UBS. Air Tran Holdings…
It’s the weekend, and that brings about the review of “the unusual suspects” for strange activity or for being key stocks under review for the week ahead. There are some old hat…
These are this Tuesday’s top day trader and active stock alerts. We have more detailed data on volume and price analysis with links through to VSInvestor.com on each stock: The Home Depot,…
Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so the potential treatments are often directly tied as well. We did a…
General Electric Company (NYSE: GE) is taking a bold and controversial new step into the field of embryonic stem cell research. The company has signed an exclusive license and alliance pact with…
We are seeing massive gap-ups this morning in stem cell stocks. President Obama is signing an executive order that will lift the Bush ban on funding of embryonic stem cell funding. What…
Douglas A. McIntyre Geron Corporation (NASDAQ: GERN) had a filing to sell shares that hit after teh close today. Normally this would be a cause for concern since it had a huge run recently. But…
Douglas A. McIntyre Geron Corporation (NASDAQ: GERN) announced today that the company received a verbal notice from the FDA that Geron’s Investigational New Drug (IND) submission for GRNOPC1, its cell therapy for spinal cord injury,…
Douglas A. McIntyre Despite not knowing whom the ultimate winner of the 2008 Presidential election will be, it looks like stem cells may be one of the real bright spots as far as which area…
Douglas A. McIntyre These are not the only pre-market analyst calls that are moving stocks, but these are the calls that 247WallSt.com is focusing on: ADC Telecom (NASDAQ: ADCT) and Arris (NASDAQ: ARRS) raised to…
Today has been a rough day with more 52-week lows than we can recall in quite some time. The biotechs haven’t been immune. You can even see that the Biotech HOLDRs (BBH)…
